KYVERNA Therapeutics

OverviewSuggest Edit

KYVERNA Therapeutics is a cell therapy company generating treatments and potential cures for serious autoimmune diseases. It develops a therapeutic platform that combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases. 

TypePrivate
Founded2018
HQBerkeley, US
Websitekyvernatx.com

Locations

KYVERNA Therapeutics is headquartered in
Berkeley, United States

Location Map

Latest Updates

Employees (est.) (Jun 2020)16(+24%)

KYVERNA Therapeutics Office Locations

KYVERNA Therapeutics has an office in Berkeley
Berkeley, US (HQ)
740 Heinz Ave
Show all (1)

KYVERNA Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2018

KYVERNA Therapeutics total Funding

$25 m

KYVERNA Therapeutics latest funding size

$25 m

Time since last funding

5 months ago

KYVERNA Therapeutics investors

KYVERNA Therapeutics's latest funding round in January 2020 was reported to be $25 m. In total, KYVERNA Therapeutics has raised $25 m
Show all financial metrics

KYVERNA Therapeutics Online and Social Media Presence

Embed Graph

KYVERNA Therapeutics Frequently Asked Questions

  • When was KYVERNA Therapeutics founded?

    KYVERNA Therapeutics was founded in 2018.

  • How many employees does KYVERNA Therapeutics have?

    KYVERNA Therapeutics has 16 employees.

  • Who are KYVERNA Therapeutics competitors?

    Competitors of KYVERNA Therapeutics include Spiderwort, Western Oncolytics and LEUKOCARE.

  • Where is KYVERNA Therapeutics headquarters?

    KYVERNA Therapeutics headquarters is located at 740 Heinz Ave, Berkeley.

  • Where are KYVERNA Therapeutics offices?

    KYVERNA Therapeutics has an office in Berkeley.

  • How many offices does KYVERNA Therapeutics have?

    KYVERNA Therapeutics has 1 office.